|
| 36566906 | Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 37059334 | Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study. | Radiother Oncol | 2023 |
| 34774650 | Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. | Radiother Oncol | 2022 |
| 35948037 | NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022. | J Natl Compr Canc Netw | 2022 |
| 35272646 | Syndrome of inappropriate secretion of antidiuretic hormone following high dose rate brachytherapy for prostate cancer: a case report. | BMC Urol | 2022 |
| 32861817 | NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2021 |
| 33544390 | Automated contour propagation of the prostate from pCT to CBCT images via deep unsupervised learning. | Med Phys | 2021 |
| 33905566 | MR to ultrasound image registration with segmentation-based learning for HDR prostate brachytherapy. | Med Phys | 2021 |
| 33674398 | PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer. | J Nucl Med | 2021 |
| 34972513 | A personalized decision aid for prostate cancer shared decision making. | BMC Med Inform Decis Mak | 2021 |
| 34585025 | Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. | Adv Radiat Oncol | 2021 |
| 34205398 | Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality. | Cancers (Basel) | 2021 |
| 33035622 | Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. | Radiother Oncol | 2021 |
| 32135513 | Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2020 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 33012016 | Automatic intraprostatic lesion segmentation in multiparametric magnetic resonance images with proposed multiple branch UNet. | Med Phys | 2020 |
| 32583418 | A deep learning framework for prostate localization in cone beam CT-guided radiotherapy. | Med Phys | 2020 |
| 32542758 | Deep learning applications in automatic needle segmentation in ultrasound-guided prostate brachytherapy. | Med Phys | 2020 |
| 30536442 | Dosimetric features-driven machine learning model for DVH prediction in VMAT treatment planning. | Med Phys | 2019 |
| 31302347 | Incorporating imaging information from deep neural network layers into image guided radiation therapy (IGRT). | Radiother Oncol | 2019 |
| 31454725 | Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer. | Transl Oncol | 2019 |
| 31276777 | Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2019 |
| 30735235 | Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. | JAMA Netw Open | 2019 |
| 31082805 | Incorporating dosimetric features into the prediction of 3D VMAT dose distributions using deep convolutional neural network. | Phys Med Biol | 2019 |
| 30759696 | Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline. | J Urol | 2019 |
| 30597561 | Prostate cancer classification with multiparametric MRI transfer learning model. | Med Phys | 2019 |
| 30307776 | Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. | J Clin Oncol | 2018 |
| 30050790 | Radiation therapy for prostate cancer. | Transl Androl Urol | 2018 |
| 30181416 | NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. | J Natl Compr Canc Netw | 2018 |
| 30322661 | Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. | Pract Radiat Oncol | 2018 |
| 28727487 | Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. | J Oncol Pract | 2017 |
| 28463168 | In Regard to Morris et al. | Int J Radiat Oncol Biol Phys | 2017 |
| 28222223 | Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. | CA Cancer J Clin | 2017 |
| 28376214 | Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer. | J Natl Cancer Inst | 2017 |
| 28244422 | Robust Estimation of Electron Density From Anatomic Magnetic Resonance Imaging of the Brain Using a Unifying Multi-Atlas Approach. | Int J Radiat Oncol Biol Phys | 2017 |
| 28501507 | Peering over the chasm: Diffusion of prostate radiation therapy hypofractionation. | Pract Radiat Oncol | 2017 |
| 28982750 | Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2017 |
| 26948397 | Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable? | Eur Urol | 2016 |
| 27697976 | NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. | J Natl Compr Canc Netw | 2016 |
| 27382001 | Electronic Release of Pathology and Radiology Results to Patients: Opinions and Experiences of Oncologists. | J Oncol Pract | 2016 |
| 26850649 | SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. | Pract Radiat Oncol | 2016 |
| 25595491 | Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer. | Med Dosim | 2015 |
| 25835615 | Oncology scan-New treatment and no treatment: enduring issues in the management of prostate cancer. | Int J Radiat Oncol Biol Phys | 2015 |
| 25963053 | Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled. | Radiother Oncol | 2015 |
| 25680591 | The case for prostate brachytherapy in the Affordable Care Act era. | Int J Radiat Oncol Biol Phys | 2015 |
| 25697335 | Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment. | J Cancer Surviv | 2015 |
| 25424586 | Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. | Pract Radiat Oncol | 2015 |
| 24055009 | Examining the evidence in pursuit of the highest possible brachytherapy standards. | Brachytherapy | 2014 |
| 25337135 | Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy. | J Contemp Brachytherapy | 2014 |
| 25130566 | Radiobiological modeling and the study of hypofractionated radiotherapy for prostate cancer. | Eur Urol | 2014 |